Comparison of efficacy of topical 0.025 % Dutasteride plus 5 % Minoxidil solution vs topical Minoxidil 5 % alone in male androgenetic alopecia - a randomised open label pilot study

The patients meeting all the inclusion criteria and not meeting any exclusion criteria shall be considered to participate in the study. ·       A detailed history including the duration of disease , associated medical conditions , treatment history and family history is to be taken. ·       The patients are randomized according to random  number generator and allocated to two interventional group. ·       Assessor shall be blinded. ·       Two medications shall be given. ·       One group will be given topical dutasteride 0.025% morning time and 5% minoxidil solution at night time for 24 weeks. ·       The other group will be given topical minoxidil  5% twice daily for 24weeks. ·       Follow up is done at baseline and after recruitment into trial every 4weeks for 24weeks. ·       The outcome will be based on photographic assessment  and quantitative assessment using densitometer. ·       Any patient developing side effects  or severe pain  shall be pulled out of intervention. Clinical photographic assessment and quantitative assessment using densitometer will be done every 4 weeks till 24weeks with due care the patients identity is not revealed.